2 TSX Growth Stocks I’d Buy and Hold Forever

Shopify (TSX:SHOP) and Docebo (TSX:DCBO) are misunderstood growth stocks that could soar in 2023.

| More on:

It seems like all we’ve heard about this year is chatter over the looming recession: how bad it will be, how long it will last, and what kind of damage it’ll inflict on our portfolios.

After the 2022 bear market in stocks and severe pressure on bonds, many Canadian investors are likely feeling anxious about checking their holdings. It’s a turbulent time. The Federal Reserve and Bank of Canada are hiking rates, even though they know the type of economic chaos they could cause. Indeed, inflation seems to be at top of mind for investors, consumers, and central banks around the world.

As we enter 2023, a recession is likely to work its course. Though the Bank of Canada thinks the storm is up ahead, many pundits also view the coming recession as a relatively mild one. Indeed, if central banks can pause or take a dovish pivot after the current tightening cycle, there’s a good chance that a soft landing can happen and corporate earnings can continue to climb, albeit at a slightly slower rate.

In any case, I think too many investors are discounting the potential for a huge turnaround in TSX growth stocks. Specifically, the growth plays that have already shed more than 60-80% of their value from peak to trough.

Sure, higher rates don’t bode well for high-multiple growth stocks lacking in profitability prospects. That said, there must a be a line in the sand drawn for such difficult-to-value securities. My guess is that such growth stocks have already been oversold. In that case, a correction to the upside could be in the cards within the next two to three years.

Consider Shopify (TSX:SHOP)(NYSE:SHOP) and Docebo (TSX:DCBO)(NASDAQ:DCBO), two misunderstood growth stocks that seem more like bargains right now.

Shopify

It’s hard to believe Shopify has fallen more than 82% from its peak. It’s been a nasty plunge after the perfect storm caused Tobias Lütke’s innovative e-commerce firm to implode. Though investors aren’t a fan of the trajectory ahead of a recession, I do view Shopify as still the top innovator in the Canadian tech scene. And right now, investors are paying a fraction (less than a fifth) for SHOP stock of what they would have paid last year.

Shopify’s growth story is still strong, with a world of opportunity online (and now offline, with Shopify’s newly unveiled point-of-sales solution). Though getting into logistics, with the recent acquisition of Deliverr, complicates matters, I do think investors should put their faith in management as they transition through what seems to be a slight pivot amidst mounting macro headwinds.

Logistics is a tough game to compete in, and it could hurt Shopify’s profitability prospects for years to come. However, I do think many investors are too impatient to give the firm a chance to prove it can thrive in new market parallels.

Remember, Shopify stock surprised us all before, and I think it will do so again. At 8.2 times sales, I view SHOP stock as severely undervalued.

Docebo

Docebo is another pandemic winner that has crashed, shedding more than 60% of its value from peak to trough.

The $1.3 billion firm, which provides AI-powered LMS (Learning Management System) software for clients to improve their remote productivity, may be down and out, but it’s still innovating. With such a magnificent product that’s more than able to keep growing on the other side of this recession, I view the plunge in the stock as an overreaction.

Docebo may not be sustainability profitable yet. But its recent quarterly beat was encouraging ($0.06 EPS vs. expectations of a $0.07 per-share loss). I think Docebo’s on the right track, and as it continues harnessing the power of AI, the stock could be quick to turn once rates pause and reverse.

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium service or advisor. We’re Motley! Questioning an investing thesis — even one of our own — helps us all think critically about investing and make decisions that help us become smarter, happier, and richer, so we sometimes publish articles that may not be in line with recommendations, rankings or other content.

Fool contributor Joey Frenette has no position in any of the stocks mentioned. The Motley Fool has positions in and recommends Shopify. The Motley Fool recommends Docebo Inc. The Motley Fool has a disclosure policy.

More on Tech Stocks

Man data analyze
Tech Stocks

3 Reasons Celestica Stock Is a Screaming Buy Now

These three reasons make Celestica stock a screaming buy for long-term investors.

Read more »

profit rises over time
Dividend Stocks

These 2 Dow Stocks Are Set to Soar in 2025 and Beyond

Two Dow Jones stocks are screaming buys but Canadians must hold them in an RRSP or RRIF to avoid paying…

Read more »

telehealth stocks
Tech Stocks

Well Health Stock: Buy, Sell, or Hold?

Another record-breaking quarter and strong demand sets the stage for continued momentum for Well Health stock.

Read more »

3 colorful arrows racing straight up on a black background.
Dividend Stocks

TSX Stocks Soaring Higher With No Signs of Slowing

Three TSX stocks continue to beat the market and could soar higher in an improving investment landscape.

Read more »

profit rises over time
Tech Stocks

2 Non-AI Tech Stocks to Buy in November for Better Returns

Not all AI stocks are riding the hype train, and for many investors, well-understood and predictable growth stocks might be…

Read more »

worry concern
Tech Stocks

In a Few Years, You’ll Probably Regret Not Owning BlackBerry Stock

Here’s why I believe BlackBerry could be one of the most overlooked Canadian tech stocks right now.

Read more »

A worker uses a double monitor computer screen in an office.
Tech Stocks

Is Constellation Software Stock a Buy for its 0.25% Dividend Yield?

Here's what investors may want to consider when it comes to Dollarama (TSX:DOL) and its relatively low dividend yield.

Read more »

Nurse talks with a teenager about medication
Tech Stocks

Shares of WELL Health Just Zoomed. Is It a Buy?

Given its improving financials and healthy growth prospects, WELL Health could deliver superior returns over the next three years.

Read more »